BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26021753)

  • 1. Managing intrathecal drug delivery (ITDD) in cancer patients.
    Shah R; Baqai-Stern A; Gulati A
    Curr Pain Headache Rep; 2015 Jun; 19(6):20. PubMed ID: 26021753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for evaluating the use of intrathecal drug delivery in the oncologic patient.
    Gulati A; Puttanniah V; Hung J; Malhotra V
    Curr Pain Headache Rep; 2014 Feb; 18(2):391. PubMed ID: 24407749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal drug delivery for management of cancer and noncancer pain.
    Simpson KH; Jones I
    J Opioid Manag; 2008; 4(5):293-304. PubMed ID: 19070267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic intrathecal drug administration for the control of intractable pain].
    Taira T
    Brain Nerve; 2008 May; 60(5):509-17. PubMed ID: 18516973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History and present state of targeted intrathecal drug delivery.
    Rizvi S; Kumar K
    Curr Pain Headache Rep; 2015; 19(2):474. PubMed ID: 25638694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
    Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
    J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal opioids for intractable pain syndromes.
    Koulousakis A; Kuchta J; Bayarassou A; Sturm V
    Acta Neurochir Suppl; 2007; 97(Pt 1):43-8. PubMed ID: 17691355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: a case report.
    Wilkes D; Cook M; Solanki D
    Pain Physician; 2010; 13(2):151-6. PubMed ID: 20309381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal therapy for chronic pain: current trends and future needs.
    Hayek SM; Hanes MC
    Curr Pain Headache Rep; 2014 Jan; 18(1):388. PubMed ID: 24338701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain management, including intrathecal pumps.
    Smith TJ; Swainey C; Coyne PJ
    Curr Oncol Rep; 2004 Jul; 6(4):291-6. PubMed ID: 15161583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intrathecal bupivacaine: how important is the flow rate?
    Buchser E; Durrer A; Chédel D; Mustaki JP
    Pain Med; 2004 Sep; 5(3):248-52. PubMed ID: 15367302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraxial pain relief for intractable cancer pain.
    Sloan PA
    Curr Pain Headache Rep; 2007 Aug; 11(4):283-9. PubMed ID: 17686392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrathecal implantable infusion pumps in the treatment of refractory pain--report of 3 cases].
    Wang RZ; Tao W; Ren ZY; Su CB; Yang Y; Zhang B; Ma WB; Yang Z; Gong ZY; Ye TH
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1746-9. PubMed ID: 15569443
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
    Zheng S; He L; Yang X; Li X; Yang Z
    Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
    Mitchell A; McGhie J; Owen M; McGinn G
    Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal drug delivery system (IDDS) for cancer pain management: a review and updates.
    Upadhyay SP; Mallick PN
    Am J Hosp Palliat Care; 2012 Aug; 29(5):388-98. PubMed ID: 22089523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal drug therapy for long-term pain management.
    Ghafoor VL; Epshteyn M; Carlson GH; Terhaar DM; Charry O; Phelps PK
    Am J Health Syst Pharm; 2007 Dec; 64(23):2447-61. PubMed ID: 18029950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of severe cancer pain via spinal catheters].
    Andersen JS; Markers PI; Valentin N
    Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
    Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.